For each 2.5 mg injection of Mounjaro (tirzepatide), what volume in cubic centimeters (cc) is delivered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mounjaro 2.5 mg Injection Volume

Each 2.5 mg injection of Mounjaro delivers 0.5 mL (0.5 cc) of solution.

According to the FDA drug label, all Mounjaro doses—including the 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg strengths—are formulated as 0.5 mL solutions 1. The concentration varies between products, but the injection volume remains constant at 0.5 mL per dose regardless of the strength.

Key Points About Mounjaro Dosing

  • Volume per injection: 0.5 mL (or 0.5 cc) for all doses 1
  • Available as: Single-dose pens or single-dose vials 1
  • Route: Subcutaneous injection 1
  • Frequency: Once weekly 1

The 2.5 mg dose specifically contains 2.5 mg of tirzepatide dissolved in 0.5 mL of solution, along with excipients including sodium chloride (4.1 mg), sodium phosphate dibasic heptahydrate (0.7 mg), and water for injection 1.

This standardized 0.5 mL volume across all Mounjaro strengths simplifies administration and reduces the risk of dosing errors, as patients and providers always inject the same volume regardless of which dose strength is prescribed.

Related Questions

For a patient undergoing spinal cord stimulator implantation, what are the instructions for stopping and restarting tirzepatide?
Should Zepbound (tirzepatide) be titrated up to the maximum dose as tolerated?
Can Mounjaro (tirzepatide) injections be administered every 10 days instead of the approved weekly schedule?
After being off tirzepatide (Zepbound) for 3 weeks, can I increase the dose from 10 mg to 12.5 mg weekly?
What treatment recommendations are appropriate for a 42‑year‑old woman taking escitalopram (Lexapro) 10 mg daily, tirzepatide (Zepbound) 12.5 mg weekly, metformin 1000 mg daily, and spironolactone 100 mg daily who has chronic fatigue, intermittent heat intolerance, brain fog, and irritability?
Should thyroid stimulating hormone (TSH) be measured in patients aged 65 or older who present with new‑onset atrial fibrillation?
What can a patient expect when initiating atomoxetine (Strattera) treatment, including side effects and onset of therapeutic benefit?
Does labetalol affect the plasma aldosterone-to-renin activity ratio?
What are the active ingredients in the inhaled medication Breztri (beclomethasone dipropionate, formoterol fumarate, glycopyrrolate)?
What is the prognosis for oligodendroglioma based on tumor grade, 1p/19q co-deletion, IDH mutation, patient age, and extent of surgical resection?
What are the differences in cardiotoxicity between trastuzumab and anthracyclines, and how should they be monitored and managed in patients receiving HER2‑positive breast cancer therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.